Or Matan, Devriendt Nausikaa, Kitshoff Adriaan M, Peremans Kathelijne, Vandermeulen Eva, Paepe Dominique, Polis Ingeborgh, Martlé Valentine, de Rooster Hilde
Am J Vet Res. 2017 Nov;78(11):1313-1318. doi: 10.2460/ajvr.78.11.1313.
OBJECTIVE To compare ammonia concentrations in arterial blood, venous blood, and CSF samples of dogs with and without extrahepatic portosystemic shunts (EHPSS). ANIMALS 19 dogs with congenital EHPSS and 6 healthy control dogs. PROCEDURES All dogs underwent a physical examination and then were anesthetized for transsplenic portal scintigraphy to confirm the presence or absence of EHPSS. While dogs were anesthetized, arterial and venous blood samples and a CSF sample were simultaneously collected for determination of ammonia concentration, which was measured by use of a portable blood ammonia analyzer (device A) and a nonportable biochemical analyzer (device B). Results were compared between dogs with EHPSS and control dogs. RESULTS Arterial, venous, and CSF ammonia concentrations for dogs with EHPSS were significantly greater than those for control dogs. For dogs with EHPSS, ammonia concentrations in both arterial and venous blood samples were markedly increased from the reference range. There was a strong positive correlation between arterial and venous ammonia concentrations and between blood (arterial or venous) and CSF ammonia concentrations. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that blood and CSF ammonia concentrations in dogs with EHPSS were greater than those for healthy dogs and were strongly and positively correlated, albeit in a nonlinear manner. This suggested that the permeability of the blood-brain barrier to ammonia may be abnormally increased in dogs with EHPSS, but further investigation of the relationship between blood or CSF ammonia concentration and clinical signs of hepatic encephalopathy or the surgical outcome for dogs with EHPSS is warranted.
目的 比较患有和未患有肝外门体分流(EHPSS)的犬的动脉血、静脉血和脑脊液样本中的氨浓度。动物 19 只患有先天性 EHPSS 的犬和 6 只健康对照犬。步骤 所有犬均接受体格检查,然后麻醉以进行经脾门静脉闪烁显像,以确认是否存在 EHPSS。在犬麻醉期间,同时采集动脉血和静脉血样本以及脑脊液样本,用于测定氨浓度,使用便携式血氨分析仪(设备 A)和非便携式生化分析仪(设备 B)进行测量。比较患有 EHPSS 的犬和对照犬的结果。结果 患有 EHPSS 的犬的动脉血、静脉血和脑脊液氨浓度显著高于对照犬。对于患有 EHPSS 的犬,动脉血和静脉血样本中的氨浓度均明显高于参考范围。动脉血和静脉血氨浓度之间以及血液(动脉血或静脉血)和脑脊液氨浓度之间存在强正相关。结论及临床意义 结果表明,患有 EHPSS 的犬的血液和脑脊液氨浓度高于健康犬,且呈强正相关,尽管是非线性的。这表明患有 EHPSS 的犬血脑屏障对氨的通透性可能异常增加,但有必要进一步研究血液或脑脊液氨浓度与肝性脑病临床症状或患有 EHPSS 的犬的手术结果之间的关系。